Description
"Breaking Alzheimer's" is Dr. Goodenowe's personal story about his journey to the discovery of plasmalogens. Low plasmalogen levels are what cause Alzheimer's disease. Thanks to this discovery and the growing body of science that followed this revelation, Alzheimer's patients now have plasmalogens tests and supplements available to them. The book provides the reader with an overview of where we are currently on this journey and where we're headed.
Support the Author
At this time, the author does not have an official website or active social media channels on platforms like Instagram, Facebook, or Twitter—or they are currently unknown to us. If any updates come to light, we’ll include them here so you can stay connected.
About The Author
Dayan Goodenowe (PhD) is a neuroscientist and founder of Prodrome Sciences, focusing on the biochemical causes of neurological diseases. His book, "Breaking Alzheimer’s: A 15-Year Crusade to Expose the Cause and Deliver the Cure" (2021), highlights the role of low plasmalogen levels in Alzheimer’s. Goodenowe explains his research and explores plasmalogen supplementation as a potential treatment.
Dayan Goodenowe (PhD) is a neuroscientist and founder of Prodrome Sciences, focusing on the biochemical causes of neurological diseases. His book, "Breaking Alzheimer’s: A 15-Year Crusade to Expose the Cause and Deliver the Cure" (2021), highlights the role of low plasmalogen levels in Alzheimer’s. Goodenowe explains his research and explores plasmalogen supplementation as a potential treatment.
Language
English
Topic
Physical Health, Mental Health, Chronic Illnesses
BREAKING ALZHEIMER'S
BREAKING ALZHEIMER'S
ISBN 10|13
XXXXXXXXXX | 979-8521279111
Print Length
242 pages